Order Article Reprints

Conticello C, Romano A, Del Fabro V, Martino EA, Calafiore V, Sapienza G, Leotta V, Parisi MS, Markovic U, Garibaldi B, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. Journal of Clinical Medicine. 2019; 8(6):877. https://doi.org/10.3390/jcm8060877

Conticello, Concetta, Alessandra Romano, Vittorio Del Fabro, Enrica Antonia Martino, Valeria Calafiore, Giuseppe Sapienza, Valerio Leotta, Marina Silvia Parisi, Uros Markovic, Bruno Garibaldi, and et al. 2019. "Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network" Journal of Clinical Medicine 8, no. 6: 877. https://doi.org/10.3390/jcm8060877

Conticello, C., Romano, A., Del Fabro, V., Martino, E. A., Calafiore, V., Sapienza, G., Leotta, V., Parisi, M. S., Markovic, U., Garibaldi, B., Leotta, S., Cotzia, E., Innao, V., Mannina, D., Neri, S., Musso, M., Scalone, R., Cangialosi, C., Acquaviva, F., ... Di Raimondo, F. (2019). Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. Journal of Clinical Medicine, 8(6), 877. https://doi.org/10.3390/jcm8060877